Watson-Marlow buys valves firm
19 May 2015
Watson-Marlow Fluid Technology Group (WMFTG) has acquired US-based valves firm Asepco through its parent company Spirax Sarco for a reported fee of £7 million.
Asepco specialises in the design and manufacture of high purity aseptic valves and magnetic mixers for the bioprocessing industry.
The acquisition strengthens Watson-Marlow’s position in the biopharmaceutical market
WMFTG president Jay Whalen
Asepco joins a product range comprising Watson-Marlow Pumps, Watson-Marlow Tubing, Flexicon Filling Systems, BioPure single-use tubing connector systems, Alitea OEM Pumps, MasoSine Process Pumps and Bredel Hose Pumps.
“The strategic acquisition of Asepco further broadens our product range and strengthens Watson-Marlow’s position in the biopharmaceutical market,” said Jay Whalen, WMFTG president.
“This enables us to provide a more comprehensive and improved service to our customers looking for sterility throughout their fluid path. This is another exciting milestone for Watson-Marlow and we are looking forward to accelerating our growth within the biopharmaceutical market with our broadened product portfolio coupled to our process expertise.”
Watson-Marlow has also confirmed that Steve Joy, president of Asepco, will remain in his role.
“I am very excited to be part of the Watson-Marlow Fluid Technology Group and look to drive sales further with the expansive WMFTG sales network,” Joy said.
